Steven Cohen’s Innodata INOD Stock Holding History

Steven Cohen’s Portfolio INOD Stock Details INOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.07M	Buy	80,337 +9,958	+14%	+$731K	0.01%	1625
2026 Q1	$2.72M	Buy	+70,379	New	+$3.51M	﹤0.01%	2112
2025 Q2	–	Sell	-32,144	Closed	-$1.15M	–	2398
2025 Q1	$1.15M	Buy	+32,144	New	+$1.41M	﹤0.01%	1398
2024 Q4	–	Sell	-12,255	Closed	-$206K	–	2243
2024 Q3	$206K	Buy	+12,255	New	+$206K	﹤0.01%	1784

Other funds holding INOD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jupiter Topco New York $245B AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Steven Cohen's INOD Position: Q2 2026 in Review

Steven Cohen increased its Innodata (INOD) stake by 14% in Q2 2026, buying an estimated $731K and bringing the position to 80,337 shares worth $6.07M. The position accounts for 0.01% of the portfolio, ranked #1625.

Steven Cohen first reported a position in INOD in Q3 2024 and has held it in 4 quarters since. 284 funds tracked by Wall St. Rank hold INOD as of Q2 2026.

Steven Cohen held 80,337 shares of Innodata worth $6.07M as of Q2 2026.
Steven Cohen bought 9,958 Innodata shares in Q2 2026, an estimated $731K.
Innodata made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1625 holding.
Steven Cohen first reported a position in Innodata in Q3 2024 and has held it in 4 quarters since.
284 funds tracked by Wall St. Rank held Innodata as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.